Alterity Therapeutics (ATHE) Change in Account Payables (2009 - 2020)

Alterity Therapeutics' Change in Account Payables history runs 11 years deep, the most recent figure standing at -$425086.2 for Q2 2020.

• On a quarterly basis, Change in Account Payables fell 191.54% year-over-year to -$425086.2 in Q2 2020; TTM through Jun 2020 was -$309780.3, a 55.35% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 million, down 280.25% from the prior year.
• Change in Account Payables fell to -$425086.2 in Q2 2020 per ATHE's latest filing, from $64066.7 in the prior quarter.
• Across five years, Change in Account Payables topped out at $464361.3 in Q2 2019 and bottomed at -$643134.5 in Q2 2017.
• The 5-year median for Change in Account Payables is -$278480.6 (2016), against an average of -$198144.3.
• Across the five-year window, Change in Account Payables jumped 5175.08% in 2019 and tumbled 191.54% in 2020, its largest moves.
• Year by year, Change in Account Payables stood at -$278480.6 in 2016, then increased by 6.83% to -$259449.8 in 2017, then plunged by 59.23% to -$413122.1 in 2018, then soared by 115.51% to $64066.7 in 2019, then slumped by 763.51% to -$425086.2 in 2020.
• Per Business Quant, the three latest ATHE Change in Account Payables figures stand at -$425086.2 (Q2 2020), $64066.7 (Q4 2019), and $464361.3 (Q2 2019).